Skip to main content
Top
Published in: Urolithiasis 6/2006

01-12-2006 | Original Paper

Chinese herbal medicines and their efficacy in treating renal stones

Authors: Mayur Danny I. Gohel, Siu Ping Wong

Published in: Urolithiasis | Issue 6/2006

Login to get access

Abstract

In herbal treatment of kidney stones, anti-lithics are used to “dissolve” the stones or aid their passing to guard against further retention. Diuretic action is also needed to increase the amount of fluid going through the kidneys and flush out the deposits. Previous clinical studies have shown that herbal medicines and their concoctions could be used to inhibit calcium oxalate crystallization. However, the pharmacodynamics and in-vitro effects of such medicines have not been established. Five Chinese herbal medicines were selected based on their usefulness in treating stone disease. A 96-well plate oxalate-induced turbidity in artificial urine was used to evaluate the efficacies of the different herbal medicines on calcium oxalate crystallization. The metastable limit was determined and the nucleation rate was derived from 12-min time-course measurement of turbidity at 405 nm. Phase-contrast microscopy was used to visualize the crystals. The results showed that with increasing concentrations of herbal extracts, smaller calcium oxalate crystal sizes were observed. Overall, the five herbal medicinal extracts tested were able to promote nucleation of calcium oxalate crystals while at the same time decreasing the size. This in-vitro crystallization confirms that prophylaxis of renal stones could be achieved by reducing overall supersaturation through promotion of small crystal nucleates and concomitant pharmacological diuretic action of herbal medicines. Clinical studies will provide more definitive conclusions.
Literature
1.
go back to reference McNamara S, Ke SX (1995) Traditional Chinese medicine. Hamish Hamilton, London, UK McNamara S, Ke SX (1995) Traditional Chinese medicine. Hamish Hamilton, London, UK
2.
go back to reference Reid DP (1999) Chinese herbal medicine. Shambala Publications Inc., Boston, USA Reid DP (1999) Chinese herbal medicine. Shambala Publications Inc., Boston, USA
3.
go back to reference Ou M, Li YW (1994) The traditional Chinese drug and its usage. Hai Feng Publishing Company, Hong Kong Ou M, Li YW (1994) The traditional Chinese drug and its usage. Hai Feng Publishing Company, Hong Kong
4.
go back to reference Li PC, Poon MKT, Ko KM (1996) Schisandra chinensis-dependent myocardial protective action of Sheng-Mai-San in rats. Am J Chin Med 24:255–262PubMedCrossRef Li PC, Poon MKT, Ko KM (1996) Schisandra chinensis-dependent myocardial protective action of Sheng-Mai-San in rats. Am J Chin Med 24:255–262PubMedCrossRef
5.
go back to reference Kou Q, Fang DY (1996) Therapeutic effects of the instant rheumatoid medicinal granules for treatment of acute rheumatoid arthritis. A report of 34 cases. J Tradit Chin Med 17:163–167 Kou Q, Fang DY (1996) Therapeutic effects of the instant rheumatoid medicinal granules for treatment of acute rheumatoid arthritis. A report of 34 cases. J Tradit Chin Med 17:163–167
6.
go back to reference Tou SX, Zhou M (1998) A clinical study on Bing Gan Ling oral liquid for treatment of hepatitis C. J Tradit Chin Med 18:209–214 Tou SX, Zhou M (1998) A clinical study on Bing Gan Ling oral liquid for treatment of hepatitis C. J Tradit Chin Med 18:209–214
7.
go back to reference Hoffman H (1983) The new holistic herbs. In: Hoffman H (eds) The urinary system. Element Books Limited, UK, pp. 108–111 Hoffman H (1983) The new holistic herbs. In: Hoffman H (eds) The urinary system. Element Books Limited, UK, pp. 108–111
8.
go back to reference Koide T, Yamaguchi S, Utsunomiya M, Yoshioka T, Sugiyama K (1995) The inhibitory effect of kampo extracts on in vitro calcium oxalate crystallization and in vivo stone formation in an animal model. Int J Urol 2:81–86PubMed Koide T, Yamaguchi S, Utsunomiya M, Yoshioka T, Sugiyama K (1995) The inhibitory effect of kampo extracts on in vitro calcium oxalate crystallization and in vivo stone formation in an animal model. Int J Urol 2:81–86PubMed
9.
go back to reference Hirayama H, Wang Z, Nishi K, Ogawa A, Ishimatu T, Ueda S, Kubo T, Nohara T (1993) Effect of Desmodium styracifolium-triterpenoid on calcium oxalate renal stones. Br J Urol 71:143–147PubMedCrossRef Hirayama H, Wang Z, Nishi K, Ogawa A, Ishimatu T, Ueda S, Kubo T, Nohara T (1993) Effect of Desmodium styracifolium-triterpenoid on calcium oxalate renal stones. Br J Urol 71:143–147PubMedCrossRef
10.
go back to reference Yasui T, Fujita K, Sato M, Sugimoto M, Iguchi M, Nomura S, Kohri K (1999) The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol Res 27:194–199PubMedCrossRef Yasui T, Fujita K, Sato M, Sugimoto M, Iguchi M, Nomura S, Kohri K (1999) The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol Res 27:194–199PubMedCrossRef
11.
go back to reference Atmani F, Khan SR (2000) Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro. BJU Int 85:621–625PubMedCrossRef Atmani F, Khan SR (2000) Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro. BJU Int 85:621–625PubMedCrossRef
12.
go back to reference Grases F, Ramis M, Costa-Bauza A, March JG (1995) Effect of Herniaria hirsuta and Agropyron repens on calcium oxalate urolithiasis risk in rats. J Ethnopharmacol 45:211–214PubMedCrossRef Grases F, Ramis M, Costa-Bauza A, March JG (1995) Effect of Herniaria hirsuta and Agropyron repens on calcium oxalate urolithiasis risk in rats. J Ethnopharmacol 45:211–214PubMedCrossRef
13.
go back to reference http://www.tcmtreatment.com. Cited 4 Sept. 2006 http://www.tcmtreatment.com. Cited 4 Sept. 2006
14.
go back to reference Zhao Z (2004) An illustrated Chinese Materia Medica in Hong Kong. School of Chinese Medicine, Hong Kong Baptist University, Hong Kong Zhao Z (2004) An illustrated Chinese Materia Medica in Hong Kong. School of Chinese Medicine, Hong Kong Baptist University, Hong Kong
15.
go back to reference Chen JK, Chen TT (2004) Chinese medical herbology and pharmacology. The Art of Medicine Press Inc., California, USA Chen JK, Chen TT (2004) Chinese medical herbology and pharmacology. The Art of Medicine Press Inc., California, USA
16.
go back to reference http://www.info.gov.hk/dh/main_ser/index.htm. Cited 4 Sept. 2006 http://www.info.gov.hk/dh/main_ser/index.htm. Cited 4 Sept. 2006
17.
go back to reference Kavanagh JP, Jones L, Rao PN (2000) Calcium oxalate crystallization kinetics studied by oxalate-induced turbidity in fresh human urine and artificial urine. Clin Sci 98:151–158PubMedCrossRef Kavanagh JP, Jones L, Rao PN (2000) Calcium oxalate crystallization kinetics studied by oxalate-induced turbidity in fresh human urine and artificial urine. Clin Sci 98:151–158PubMedCrossRef
18.
go back to reference Kavanagh JP, Jones L, Rao PN (1999) Calcium oxalate crystallization kinetics at different concentrations of human and artificial urine, with a constant calcium to oxalate ratio. Urol Res 27:231–237PubMedCrossRef Kavanagh JP, Jones L, Rao PN (1999) Calcium oxalate crystallization kinetics at different concentrations of human and artificial urine, with a constant calcium to oxalate ratio. Urol Res 27:231–237PubMedCrossRef
19.
go back to reference Holmes RP, Kennedy M (2000) Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int 57:1662–1667PubMedCrossRef Holmes RP, Kennedy M (2000) Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int 57:1662–1667PubMedCrossRef
20.
go back to reference Baumann JM, Affolter B, Brenneisen J, Siegrist HP (1997) Measurement of metastability, growth and aggregation of calcium oxalate in native urine—a new approach for clinical and experimental stone research. Urol Int 59:214–220PubMedCrossRef Baumann JM, Affolter B, Brenneisen J, Siegrist HP (1997) Measurement of metastability, growth and aggregation of calcium oxalate in native urine—a new approach for clinical and experimental stone research. Urol Int 59:214–220PubMedCrossRef
21.
go back to reference Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. J Am Med Assoc 287:337–344CrossRef Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. J Am Med Assoc 287:337–344CrossRef
22.
go back to reference Yun TK (1999) Update from Asia: Asian studies on cancer chemoprevention. Ann NY Acad Sci 889:157–192PubMedCrossRef Yun TK (1999) Update from Asia: Asian studies on cancer chemoprevention. Ann NY Acad Sci 889:157–192PubMedCrossRef
23.
go back to reference Yuen JWM, Gohel MDI (2005) Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 53:11–17PubMedCrossRef Yuen JWM, Gohel MDI (2005) Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 53:11–17PubMedCrossRef
24.
go back to reference http://www.cmchk.org.hk/eindex.htm. Cited 4 Sept. 2006 http://www.cmchk.org.hk/eindex.htm. Cited 4 Sept. 2006
25.
go back to reference http://alternativehealing.org/traditional_chinese_medicine.htm. Cited 4 Sept. 2006 http://alternativehealing.org/traditional_chinese_medicine.htm. Cited 4 Sept. 2006
26.
go back to reference Gohel MDI, Shum DKY, Li MK (1994) Crystallization of urinary calcium oxalate at standardized osmolality and pH in the frozen state. Clin Chim Acta 231:11–22PubMedCrossRef Gohel MDI, Shum DKY, Li MK (1994) Crystallization of urinary calcium oxalate at standardized osmolality and pH in the frozen state. Clin Chim Acta 231:11–22PubMedCrossRef
27.
go back to reference Roehrborn CG, Schneider HJ, Rugendorff EW (1986) Determination of stone-forming risk by measuring crystal formation in whole urine with gel model. Urology 27:531–536PubMedCrossRef Roehrborn CG, Schneider HJ, Rugendorff EW (1986) Determination of stone-forming risk by measuring crystal formation in whole urine with gel model. Urology 27:531–536PubMedCrossRef
28.
go back to reference Li MK, Shum DKY, Choi S (1987) Detection of crystallization inhibitory activity of whole urine with a gel model. Urol Res 15:75–77PubMedCrossRef Li MK, Shum DKY, Choi S (1987) Detection of crystallization inhibitory activity of whole urine with a gel model. Urol Res 15:75–77PubMedCrossRef
29.
go back to reference Hess B, Meinhardt U, Zipperle L, Giovanoli R, Jaeger P (1995) Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: impact of various modifiers. Urol Res 23:231–238PubMedCrossRef Hess B, Meinhardt U, Zipperle L, Giovanoli R, Jaeger P (1995) Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: impact of various modifiers. Urol Res 23:231–238PubMedCrossRef
31.
go back to reference Brenner BM (2004) The kidney, 7th edn. In: Brenner BM, Rector FC Jr (eds) Saunders, Philadelphia, USA Brenner BM (2004) The kidney, 7th edn. In: Brenner BM, Rector FC Jr (eds) Saunders, Philadelphia, USA
Metadata
Title
Chinese herbal medicines and their efficacy in treating renal stones
Authors
Mayur Danny I. Gohel
Siu Ping Wong
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 6/2006
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-006-0068-y

Other articles of this Issue 6/2006

Urolithiasis 6/2006 Go to the issue